CAS Shanghai Primate SCNT Pipeline
State-coordinated primate-cloning substrate monopoly — Chinese Academy of Sciences, 2018-
2024: Retro, first SCNT-cloned rhesus monkey, born via trophoblast-replacement method overcoming placental defects. 2025: International Consortium for Primate Brain Mapping (ICPBM) launched — 25-year multiomic primate-brain atlas initiative, heavily state-subsidized.
Engine Framing: NOT a 'the next dominant power (engine-tracked claim)' narrative (centralized power structure node-framing binding) — the pattern is substrate monopolization. CAS now possesses exclusive infrastructure to mass-produce genetically identical primate models for neurodegenerative disease + pharmaceutical pipelines. Western competition absent due to ethical / regulatory constraints. Apex (a) Coordinated-state-strategic-research load-bearing.
Also in Cloning Substrate Post-Dolly
Sooam Biotech Research FoundationSubstrate-continuation commercial node — Seoul, 20ViaGen PetsUS commercial pet cloning — Texas, 2015-Sinogene BiotechnologyChinese commercial pet cloning — Beijing, 2017-Trans Ova GeneticsIndustrial-agricultural SCNT — Iowa, 2002-Mitalipov OHSU Center for Embryonic Cell and Gene TherapyWestern academic human-SCNT + germline node — OregHe Jiankui — Post-Prison Disclosure-Window ProbeCRISPR-babies operator → Hainan post-prison continColossal BiosciencesOperator-class capital de-extinction substrate — T